Akhil Saklecha

Akhil Saklecha

Signal active

Managing Director

Bio

Akhil Saklecha focuses on early stage investments with an interest towards medical technology. As a Partner at Artiman, he has led investments in DMS Networks and Cellmax.

Akhil has over 15 years of experience in medicine and healthcare management. Prior to joining Artiman in 2010, Akhil was Medical Director of a 750 bed hospital's regional transfer program. Prior to that position, he was President and CEO of Canton Aultman Emergency Physicians, a professional services firm that provides physicians, mid-level providers, and coding expertise to multiple hospitals and urgent care centers.

He was also Chairman of Emergency Medicine at Aultman Hospital, a large trauma, cardiac, and stroke center seeing nearly 90,000 patients annually. In this same time period, Akhil has served at the local, state, and national levels within emergency medicine, healthcare quality, information technology, managed care, and emergency medical services.

Location

San Francisco, California, United States, North America

Social

Primary Organization

Cleveland Clinic

Cleveland Clinic

Founded

1921

Investment

17

Lead investment

6

Exits

3

Employees

1001-5000

Industry

Health Care, Medical, Non Profit, Hospital

Invest in regions

Profile Resume

Akhil Saklecha is the Managing Director at Cleveland Clinic, based in United States, North America. With a background in Health Care, Akhil Saklecha has a rich history of leadership and innovation. Akhil Saklecha studied BS Integrated Life Sciences @ Kent State University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

5

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Sep 08, 2014
HomeUnion HomeUnion
Series A - HomeUnion
HomeUnion Artiman Ventures
5.5M
Jul 26, 2016
CellMax Life CellMax Life
Series A - CellMax Life
CellMax Life Artiman Ventures
9.0M
Jun 28, 2018
ApplyBoard ApplyBoard
Series A - ApplyBoard
ApplyBoard Artiman Ventures
13.0M
May 27, 2019
ApplyBoard ApplyBoard
Series B - ApplyBoard
ApplyBoard Artiman Ventures
40.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity